Sublingual human chorionic gonadotropin as an adjuvant to ovulation induction

JBRA Assist Reprod. 2024 Feb 26;28(1):13-20. doi: 10.5935/1518-0557.20230068.

Abstract

Objective: To evaluate the efficacy of sublingually administered human chorionic gonadotropin (HCG) in combination with clomiphene citrate (CC) or letrozole (LTZ) for ovulation induction.

Methods: In this prospective, double-blind, randomized study, the patients were divided into two placebo groups and two intervention groups using CC, LTZ, and HCG.

Results: There were no statistically significant differences in ovulation induction between the groups. We compared endometrial thickness at the beginning of the cycle and during the pre-ovulatory period, and detected a moderately positive correlation when CC was administered with HCG.

Conclusions: Sublingual HCG with CC caused a moderately positive correlation with endometrial thickening when compared with that at the beginning of the cycle and during the pre-ovulatory period. There was no significant change in the number of pre-ovulatory follicles.

Keywords: chorionic gonadotropin; clomiphene; letrozole; ovulation induction.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Chorionic Gonadotropin / therapeutic use
  • Clomiphene / pharmacology
  • Clomiphene / therapeutic use
  • Double-Blind Method
  • Female
  • Fertility Agents, Female / therapeutic use
  • Humans
  • Infertility, Female* / etiology
  • Letrozole
  • Nitriles / pharmacology
  • Nitriles / therapeutic use
  • Ovulation Induction / adverse effects
  • Prospective Studies
  • Triazoles / pharmacology
  • Triazoles / therapeutic use

Substances

  • Chorionic Gonadotropin
  • Clomiphene
  • Fertility Agents, Female
  • Letrozole
  • Nitriles
  • Triazoles